120 related articles for article (PubMed ID: 15090718)
1. International trends in prostate-cancer mortality: the decrease is continuing and spreading.
Baade PD; Coory MD; Aitken JF
Cancer Causes Control; 2004 Apr; 15(3):237-41. PubMed ID: 15090718
[TBL] [Abstract][Full Text] [Related]
2. International trends in prostate-cancer mortality in the "PSA ERA".
Oliver SE; May MT; Gunnell D
Int J Cancer; 2001 Jun; 92(6):893-8. PubMed ID: 11351313
[TBL] [Abstract][Full Text] [Related]
3. Screening for prostate cancer: updated experience from the Tyrol study.
Horninger W; Berger A; Pelzer A; Klocker H; Oberaigner W; Schönitzer D; Severi G; Robertson C; Boyle P; Bartsch G
Can J Urol; 2005 Feb; 12 Suppl 1():7-13; discussion 92-3. PubMed ID: 15780158
[TBL] [Abstract][Full Text] [Related]
4. Recent trends in prostate cancer mortality show a continuous decrease in several countries.
Bouchardy C; Fioretta G; Rapiti E; Verkooijen HM; Rapin CH; Schmidlin F; Miralbell R; Zanetti R
Int J Cancer; 2008 Jul; 123(2):421-429. PubMed ID: 18452171
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
6. Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: population-based estimates for the year 2000 by period analysis.
Brenner H; Arndt V
J Clin Oncol; 2005 Jan; 23(3):441-7. PubMed ID: 15572727
[TBL] [Abstract][Full Text] [Related]
7. Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964-2003 followed up until the end of 2006.
Bray F; Klint A; Gislum M; Hakulinen T; Engholm G; Tryggvadóttir L; Storm HH
Acta Oncol; 2010 Jun; 49(5):644-54. PubMed ID: 20151937
[TBL] [Abstract][Full Text] [Related]
8. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries.
Kvåle R; Auvinen A; Adami HO; Klint A; Hernes E; Møller B; Pukkala E; Storm HH; Tryggvadottir L; Tretli S; Wahlqvist R; Weiderpass E; Bray F
J Natl Cancer Inst; 2007 Dec; 99(24):1881-7. PubMed ID: 18073376
[TBL] [Abstract][Full Text] [Related]
9. Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates.
Feuer EJ; Mariotto A; Merrill R
Cancer; 2002 Aug; 95(4):870-80. PubMed ID: 12209732
[TBL] [Abstract][Full Text] [Related]
10. Downward trend in prostate cancer mortality in Quebec and Canada.
Meyer F; Moore L; Bairati I; Fradet Y
J Urol; 1999 Apr; 161(4):1189-91. PubMed ID: 10081867
[TBL] [Abstract][Full Text] [Related]
11. Decline in prostate cancer mortality from 1980 to 1997, and an update on incidence trends in Olmsted County, Minnesota.
Roberts RO; Bergstralh EJ; Katusic SK; Lieber MM; Jacobsen SJ
J Urol; 1999 Feb; 161(2):529-33. PubMed ID: 9915441
[TBL] [Abstract][Full Text] [Related]
12. Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Schröder FH
Can J Urol; 2005 Feb; 12 Suppl 1():2-6; discussion 92-3. PubMed ID: 15780157
[TBL] [Abstract][Full Text] [Related]
13. PSA screening and prostate cancer mortality.
Perron L; Moore L; Bairati I; Bernard PM; Meyer F
CMAJ; 2002 Mar; 166(5):586-91. PubMed ID: 11898936
[TBL] [Abstract][Full Text] [Related]
14. [Trends in prostate cancer mortality in Portugal (1980-2006)].
Bastos J; Botelho F; Pina F; Lunet N
Acta Med Port; 2011; 24(4):499-504. PubMed ID: 22521005
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer incidence and mortality trends in 37 European countries: an overview.
Bray F; Lortet-Tieulent J; Ferlay J; Forman D; Auvinen A
Eur J Cancer; 2010 Nov; 46(17):3040-52. PubMed ID: 21047585
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
17. Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European randomized study of screening for prostate cancer-Rotterdam after 11 years of follow-up.
Zhu X; van Leeuwen PJ; Bul M; Otto SJ; de Koning HJ; Bangma CH; Schröder FH; Roobol MJ
Eur Urol; 2011 Aug; 60(2):330-6. PubMed ID: 21601352
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer mortality predictions for Ireland up to 2015.
O'Lorcain P; Comber H
Eur J Cancer Prev; 2007 Aug; 16(4):328-33. PubMed ID: 17554205
[TBL] [Abstract][Full Text] [Related]
19. An ecologic study of prostate-specific antigen screening and prostate cancer mortality in nine geographic areas of the United States.
Shaw PA; Etzioni R; Zeliadt SB; Mariotto A; Karnofski K; Penson DF; Weiss NS; Feuer EJ
Am J Epidemiol; 2004 Dec; 160(11):1059-69. PubMed ID: 15561985
[TBL] [Abstract][Full Text] [Related]
20. Trends in prostate cancer incidence and mortality in New Mexico are consistent with an increase in effective screening.
Gilliland F; Becker TM; Smith A; Key CR; Samet JM
Cancer Epidemiol Biomarkers Prev; 1994 Mar; 3(2):105-11. PubMed ID: 8049631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
